コンテンツへスキップ
Merck
  • [Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].

[Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].

Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases (2010-03-18)
Cong-Shan Liu, Hao-Bing Zhang
要旨

Mebendazole is currently used in the treatment of hydatid disease. Its poor absorption from the gastrointestinal tract and low bioavailability aroused further research on new formulations of mebendazole to increase the bioavailability and improve the therapeutic efficacy. This review summarizes the recent research progress.

材料
製品番号
ブランド
製品内容

USP
メベンダゾール, United States Pharmacopeia (USP) Reference Standard
Supelco
メベンダゾール, analytical standard, ≥98% (HPLC)
Supelco
メベンダゾール, VETRANAL®, analytical standard
メベンダゾール, European Pharmacopoeia (EP) Reference Standard
システム適合性用メベンダゾール, European Pharmacopoeia (EP) Reference Standard